Background: Type II refractory coeliac disease (RCD) is a rare but significant subset of RCD. 1 Diagnosis relies on detecting aberrant intraepithelial lymphocytes, with flow cytometry considered gold standard for assessment. 2 However, utility is limited by lack of assay standardisation.
Cuschieri et al. (Sun,) studied this question.